Market Snapshot

BSE Sensex: 82814.71 0.38%
BSE 500: 36674.32 0.41%
BSE 200: 11606.68 0.48%
BSE 100: 26790.87 0.43%
BSE BANKEX: 68798.21 0.77%
BSE IT: 31051.7 -0.98%
Nifty 50: 25571.25 0.46%
Nifty 500: 23395 0.42%
Nifty 200: 14280.85 0.48%
Nifty 100: 26217.3 0.49%
Nifty Midcap 100: 59513.95 0.48%
Nifty Small 100: 17002.15 -0.11%
Nifty IT: 32004.05 -0.98%
Nifty PSU Bank: 9665.8 1.68%

News:

Gulf Oil Lubricants renews mul...
ITCONS E-Solutions bags Rs 2-c...
Elgi Equipments arm establishe...
Hazoor Multi Projects bags Rs ...
Star Cements new grinding unit...

Alivus Life Sciences Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

20 Feb 2026 | 04:14 PM

910.95

20.95 (2.35%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-13.69%

Return (1Y)

Underperformed Nifty 50 by 25.29%
More Volatile

2.21%

Standard Deviation (1Y)

Higher than Nifty 50 by 1.46%
Not so consistent

5/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

1,225

819

News & Announcements

Alivus Life Sciences standalone net profit rises 9.71% in the December 2025 quarter
30 days ago

Alivus Life Sciences standalone net profit rises 9.71% in the December 2025 quarter

22 - Jan - 2026 12:00 | 30 days ago

Net profit of Alivus Life Sciences rose 9.71% to Rs 150.26 crore in the quarter ended December 2025 as against Rs 136.96 crore during the previous quarter ended December 2024. Sales rose 4.84% to Rs 672.89 crore in the quarter ended December 2025 as against Rs 641.84 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 672.89 641.84 5

OPM % 34.37 29.65 -

PBDT 243.71 200.31 22

PBT 224.05 185.15 21

NP 150.26 136.96 10

Powered by Capital Market - Live News
Alivus Life Sciences allots 55,000 equity shares under ESOS
30 days ago

Alivus Life Sciences allots 55,000 equity shares under ESOS

22 - Jan - 2026 12:00 | 30 days ago

Alivus Life Sciences has allotted 55,000 equity shares under ESOS on 21 January 2026. With this allotment, the paid up equity share capital has increased to 12,27,36,348 equity shares of Rs. 2 each aggregating to Rs. 24,54,72,696/-.
Powered by Capital Market - Live News
Alivus Life Sciences announces board meeting date
37 days ago

Alivus Life Sciences announces board meeting date

15 - Jan - 2026 12:00 | 37 days ago

Alivus Life Sciences will hold a meeting of the Board of Directors of the Company on 22 January 2026.
Powered by Capital Market - Live News
Alivus Life Sciences standalone net profit rises 36.41% in the September 2025 quarter
106 days ago

Alivus Life Sciences standalone net profit rises 36.41% in the September 2025 quarter

07 - Nov - 2025 12:00 | 106 days ago

Net profit of Alivus Life Sciences rose 36.41% to Rs 130.03 crore in the quarter ended September 2025 as against Rs 95.32 crore during the previous quarter ended September 2024. Sales rose 16.00% to Rs 587.98 crore in the quarter ended September 2025 as against Rs 506.88 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 587.98 506.88 16

OPM % 30.47 26.51 -

PBDT 192.58 142.55 35

PBT 174.14 127.46 37

NP 130.03 95.32 36

Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Glenmark Life Sciences Ltd has decreased by -25.61% since past 3 Months
MF shareholding in Glenmark Life Sciences Ltd has increased by 40.4% since past 3 Months
FII shareholding in Glenmark Life Sciences Ltd has decreased by -24.59% since past 1 Year
MF shareholding in Glenmark Life Sciences Ltd has increased by 68.67% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	672.89	641.84	5
OPM %	34.37	29.65	-
PBDT	243.71	200.31	22
PBT	224.05	185.15	21
NP	150.26	136.96	10

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	587.98	506.88	16
OPM %	30.47	26.51	-
PBDT	192.58	142.55	35
PBT	174.14	127.46	37
NP	130.03	95.32	36

General Notifications

My Notifications

Research Notifications

Alivus Life Sciences Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

910.95 20.95 (2.35%)

News & Announcements

Price vs Volume

Stock Trivia

Alivus Life Sciences Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

910.95

20.95 (2.35%)